Short answer
North Carolina had 78 pharmaceutical and medicine manufacturing establishments in 2023, employing 24,370 people at an average annual pay of $94,639 (Census County Business Patterns), 11th among states by count. Fourteen of them have 500 or more employees. FDA's registration file lists sites for Novo Nordisk, Merck, Lilly, Pfizer, Grifols and FUJIFILM, among others. BioCryst of Durham is the largest listed drugmaker headquartered in the state, with $874.8 million of 2025 revenue.
- The average North Carolina drug plant has 312 employees, about three times Massachusetts' average of 100.
- Seven establishments have 1,000 or more employees and seven more have 500 to 999.
- 31 of the 78 plants sit in counties too small to publish, including Clayton, Sanford and Rocky Mount.
- Pfizer's 10-K says its Rocky Mount plant makes nearly 25% of its sterile injectables.
- BioCryst ($874.8 million) and TG Therapeutics ($616.3 million) are the largest listed drugmakers based in the state.
On this page
This report is for job seekers, suppliers and contract partners, and sellers who need to know where North Carolina's drug companies are and how big they are. It uses Census Bureau counts for plants, FDA's registration file for named sites and each listed company's 10-K for headquarters, revenue and headcount.
How North Carolina's plants compare
County Business Patterns (CBP) 2023, NAICS 3254 (Pharmaceutical and Medicine Manufacturing):
| Measure (2023) | North Carolina |
|---|---|
| Establishments | 78 |
| Employees | 24,370 |
| Annual payroll | $2,306,343,000 |
| Average employees per establishment | 312.4 |
| Average annual pay | $94,639 |
| Share of US establishments | 2.69% of 2,901 |
| Rank among states by establishments | 11th |
| Employees per establishment | Establishments |
|---|---|
| 1 to 4 | 16 |
| 5 to 9 | 7 |
| 10 to 19 | 6 |
| 20 to 49 | 9 |
| 50 to 99 | 10 |
| 100 to 249 | 11 |
| 250 to 499 | 5 |
| 500 to 999 | 7 |
| 1,000 or more | 7 |
Every size class is published for North Carolina. Thirty establishments have 100 or more employees, against 29 with fewer than 20. By product, 41 establishments make finished-dose pharmaceuticals (325412, 16,424 employees) and 22 make biological products such as vaccines, plasma proteins and gene therapies (325414, 6,028 employees); 12 make medicinal chemicals and botanicals, and 3 make diagnostic substances.
What the plant count leaves out
Each CBP establishment is one location with a payroll, so a company with three plants counts three times; the self-employed aren't counted. Code 3254 covers manufacturing only. Research labs, head offices and distributors are classed elsewhere, and in North Carolina they're large: the same 2023 data shows 252 biotechnology R&D establishments (NAICS 541714) with 7,031 employees and 230 drug wholesale establishments (NAICS 424210) with 8,031.
Counties: published and hidden
| County | Establishments | Employees |
|---|---|---|
| Durham | 15 | 3,979 |
| Wake | 8 | 1,958 |
| Pitt | 4 | 2,570 |
| Wilson | 4 | 620 |
| Forsyth | 4 | 105 |
| Guilford | 4 | not reported (high-noise figure) |
| Iredell | 4 | not reported (high-noise figure) |
| Mecklenburg | 4 | not reported (high-noise figure) |
"Not reported" means the Census Bureau published the total but flagged it as high-noise: its confidentiality noise moved the value by 5% or more. These eight counties hold 47 of the 78 establishments. The other 31 are in counties with one or two plants each, which the Census Bureau doesn't publish (it releases a county cell only when it holds three or more establishments). FDA's file shows where many of them are: Johnston County (Clayton), Lee County (Sanford), Rocky Mount, Cabarrus County (Concord) and McDowell County (Marion).
The big registered sites
FDA's Drug Establishments Current Registration Site (DECRS) lists 233 registered drug establishments in North Carolina in our count of the 30 October 2026 download: 104 that make finished drugs or active ingredients, 50 medical gas suppliers (our classification by firm name), 32 medicated animal feed mills, 27 packers or relabelers, 16 testing labs and 4 others. Durham (31) and Morrisville (17) have the most. The largest manufacturing names, by town:
| Town | Registered manufacturing sites (FDA file) |
|---|---|
| Durham and RTP | Merck Sharp & Dohme, Merck Teknika, Eli Lilly, Novo Nordisk, Novartis, KBI Biopharma, FUJIFILM Diosynth, United Therapeutics |
| Clayton | Novo Nordisk, Grifols Therapeutics |
| Holly Springs | FUJIFILM Diosynth, Seqirus |
| Sanford | Wyeth (registered to "a subsidiary of Pfizer Inc."), Astellas Gene Therapies |
| Rocky Mount | Hospira |
| Wilson | Merck Sharp & Dohme |
| Greenville | Patheon Manufacturing Services, Catalent Greenville |
| Concord | Eli Lilly |
| Zebulon | GlaxoSmithKline |
| Marion | Baxter Healthcare |
The filings fill in a few of these. Pfizer's 2025 10-K says its Rocky Mount plant, damaged by a tornado in July 2023, "is responsible for manufacturing nearly 25 percent of all our sterile injectables." Lilly's 10-K names North Carolina among its major US production states. United Therapeutics gives a second principal executive office at 55 T.W. Alexander Drive, Durham. Registration is self-reported and isn't an FDA approval.
Listed drugmakers headquartered in North Carolina
SEC EDGAR shows 13 listed companies in SIC codes 2833 to 2836 with a North Carolina business address; TG Therapeutics, which EDGAR still files under New York, gives Morrisville on its latest 10-K. Checked in each 10-K:
| Company | Headquarters (10-K cover) | Revenue, 2025 | Employees reported |
|---|---|---|---|
| BioCryst Pharmaceuticals | Durham | $874.8 million | about 435 |
| TG Therapeutics | Morrisville | $616.3 million | 399 |
| Liquidia | Morrisville | $158.3 million | 216 |
| Fennec Pharmaceuticals | Research Triangle Park | $44.6 million | about 35 |
| Precision BioSciences | Durham | $34.3 million | 68 full-time |
| Pelthos Therapeutics | Durham | $16.8 million | 92 full-time |
| Opus Genetics | Durham | $14.2 million | 27 full-time |
| Humacyte | Durham | $2.0 million | 184 |
| ProKidney | Winston-Salem | $0.9 million | 231 full-time |
| Immunovant | Durham | none (year to 31 March 2026) | 315 full-time |
The rest are small: vTv Therapeutics in High Point (26 employees), Tenax Therapeutics in Chapel Hill and Adaptin Bio in Charlotte. The global owners of the big plants rank in the largest pharmaceutical companies.
Checking a North Carolina company
- Distributor licence. FDA lists the North Carolina Department of Agriculture and Consumer Services, not the pharmacy board, as the agency that licenses wholesale drug distributors in the state.
- Inspection history. FDA's Data Dashboard shows inspections, warning letters and recalls by site.
- Training and hiring routes. The state Commerce Department lists the BTEC biomanufacturing center at NC State and the BRITE institute at North Carolina Central University among its training programs.
- The network. NCLifeSci, the state's life sciences trade association, has a member directory and an events calendar.
Prospecting North Carolina plants
| Plant size (CBP) | Establishments | Who decides |
|---|---|---|
| 1,000 or more employees | 7 | Site leadership with corporate procurement; long cycles, master agreements |
| 250 to 999 | 12 | Plant manager, engineering and quality heads |
| 50 to 249 | 21 | Operations or general manager |
| Under 50 | 38 | Owner or a single operations lead |
Worked example: a calibration lab
Illustrative example. The lab and its prices are invented; the counts come from CBP 2023.
Piedmont Metrology (piedmontmetrology.example) calibrates balances, pipettes, temperature sensors and other instruments under GMP.
- Pick the tier. The 23 plants with 100 to 999 employees run enough instruments to outsource calibration but often lack an in-house team.
- Map the drive. Durham, Wake, Johnston, Pitt and Wilson counties, where FDA's file shows many of the big sites, are all within two hours of Raleigh.
- Do the arithmetic. If 30% of the 23 take a quote (7) and 4 sign at $55,000 a year each, that's $220,000 of recurring work, plus audit-driven extras.
Finding the metrology or quality lead at each plant is the slow part; Bebop researches each account and suggests who to contact.
Next step: zoom in on Wake and Johnston counties in the Raleigh pharmaceutical market report.
Sources
- County Business Patterns (CBP), 2023, US Census Bureau, accessed 30 October 2026
- 2023 County Business Patterns datasets (state and county files, NAICS 3254, 424210 and 541714), US Census Bureau, accessed 30 October 2026
- County Business Patterns methodology (publication rule and noise flags), US Census Bureau, accessed 30 October 2026
- Drug Establishments Current Registration Site (DECRS), US Food and Drug Administration, accessed 30 October 2026
- DECRS annual registration status download (drls_reg.zip), US Food and Drug Administration, accessed 30 October 2026
- Check licensure of wholesale drug distributors and third-party logistics providers, US Food and Drug Administration, accessed 30 October 2026
- FDA Data Dashboard, US Food and Drug Administration, accessed 30 October 2026
- Pfizer Inc. Form 10-K for 2025 (Rocky Mount, North Carolina), Pfizer Inc., via SEC EDGAR, filed 26 February 2026
- Eli Lilly and Company Form 10-K for 2025 (Item 2, Properties), Eli Lilly and Company, via SEC EDGAR, filed 12 February 2026
- United Therapeutics Form 10-K for 2025, United Therapeutics Corporation, via SEC EDGAR, filed 25 February 2026
- North Carolina's Research Triangle Region, Novo Nordisk Inc., accessed 30 October 2026
- BioCryst Pharmaceuticals Form 10-K for 2025, BioCryst Pharmaceuticals, Inc., via SEC EDGAR, filed 26 February 2026
- TG Therapeutics Form 10-K for 2025, TG Therapeutics, Inc., via SEC EDGAR, filed 27 February 2026
- Liquidia Corporation Form 10-K for 2025, Liquidia Corporation, via SEC EDGAR, filed 5 March 2026
- Fennec Pharmaceuticals Form 10-K for 2025, Fennec Pharmaceuticals Inc., via SEC EDGAR, filed 27 March 2026
- Precision BioSciences Form 10-K for 2025, Precision BioSciences, Inc., via SEC EDGAR, filed 12 March 2026
- Pelthos Therapeutics Form 10-K for 2025, Pelthos Therapeutics Inc., via SEC EDGAR, filed 19 March 2026
- Opus Genetics Form 10-K for 2025, Opus Genetics, Inc., via SEC EDGAR, filed 12 March 2026
- Humacyte Form 10-K for 2025, Humacyte, Inc., via SEC EDGAR, filed 27 March 2026
- ProKidney Form 10-K for 2025, ProKidney Corp., via SEC EDGAR, filed 18 March 2026
- Immunovant Form 10-K for the year ended 31 March 2026, Immunovant, Inc., via SEC EDGAR, filed 20 May 2026
- Biotechnology and pharmaceuticals in North Carolina, North Carolina Department of Commerce, accessed 30 October 2026
- NCLifeSci, North Carolina Life Sciences Organization, NCLifeSci, accessed 30 October 2026
Written by the Bebop team at Blackpearl Group. Published .
Questions people ask
How many pharmaceutical companies are in North Carolina?
Census County Business Patterns counted 78 pharmaceutical and medicine manufacturing establishments in North Carolina in 2023, with 24,370 employees, plus 252 biotechnology R&D establishments and 230 drug wholesalers. FDA's drug registration file lists 233 registered sites, because it also counts gas suppliers, feed mills, packagers and labs. SEC EDGAR shows 13 listed drug companies with a North Carolina address.
What are the largest pharmaceutical plants in North Carolina?
Census data shows seven North Carolina drug establishments with 1,000 or more employees but doesn't name them. FDA's registration file lists large manufacturers including Novo Nordisk and Grifols in Clayton, Merck in Durham and Wilson, Pfizer's Wyeth unit in Sanford, Hospira in Rocky Mount and Eli Lilly in Durham and Concord. Novo Nordisk says its Clayton site employs more than 2,000 people.
What pharmaceutical companies are headquartered in North Carolina?
According to their latest 10-K filings, BioCryst Pharmaceuticals of Durham is the largest listed drugmaker headquartered in North Carolina, with $874.8 million of 2025 revenue, followed by TG Therapeutics ($616.3 million) and Liquidia ($158.3 million), both in Morrisville. Most of the large plants in the state belong to companies headquartered elsewhere, such as Novo Nordisk, Merck, Pfizer and Lilly.
How much do pharmaceutical jobs pay in North Carolina?
North Carolina's drug manufacturing establishments paid $2.31 billion to 24,370 employees in 2023, an average of $94,639 a year, according to Census County Business Patterns. That's below Massachusetts ($152,661) and Maryland ($161,237), but it covers more manufacturing jobs than either state. Research and headquarters jobs are counted in other industries.
Who licenses drug distributors in North Carolina?
FDA's list of state licensing agencies names the North Carolina Department of Agriculture and Consumer Services as the agency that licenses wholesale prescription drug distributors in North Carolina. Ask any distributor or logistics partner for its licence number and check it there. Separately, every site that makes, packs or tests drugs for the US market registers with FDA, which publishes the list.